Mediana Co (041920) Fair Value & Analysis
Healthcare · KR · Market cap 180B KRW
Fair value as of: Jul 20, 2026
From 26 valuation models · updated 21 days ago
Share price −5.6% over the past month.
A solid business, but screening 35% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (7,861 KRW). The favourable scenario is already priced in.
- Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.
How to read this chart
60‑month range 3,733 KRW – 28,650 KRW · fair‑value band 4,717 KRW – 7,861 KRW · the 9,720 KRW price screens above the 6,289 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 20, 2026.
Analysis
Mediana Co (041920) currently trades at 9,720 KRW, while our model-based Fair Value estimate is 6,289 KRW, implying the stock looks roughly 35.3% overvalued today. The Quality Score stands at 61/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Mediana Co generated revenue of 65.0B KRW at a net margin of 21.9%. Revenue grew 59.8% year over year. Fundamentals as of Jul 20, 2026
Our scenario range runs from 4,717 KRW (bear case) to 7,861 KRW (bull case); at 9,720 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 67% below its 52-week high and 100% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -2% fair-value upside, at -35%, 041920 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (6,764 KRW) versus Dividend Discount (336.94 KRW). Highest evidence: Growth DCF (80).
Notify me when 041920 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 58 · Market factors (momentum, volatility) 45
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Mediana Co.,Ltd, together with its subsidiaries, develops, manufactures, and sells medical devices in South Korea. It offers patient monitors, vital signs monitors, AEDs, monitors/defibrillators, fetal products, body composition analyzers, central monitoring systems, face masks, spot checks and monitors, pulse oximeters, and physio modules.
Full company description
Mediana Co.,Ltd, together with its subsidiaries, develops, manufactures, and sells medical devices in South Korea. It offers patient monitors, vital signs monitors, AEDs, monitors/defibrillators, fetal products, body composition analyzers, central monitoring systems, face masks, spot checks and monitors, pulse oximeters, and physio modules. The company also exports ODM and own branded products through agencies in approximately 80 countries. Mediana Co.,Ltd was founded in 1993 and is headquartered in Wonju-si, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Mediana Co reported revenue of 64.9B KRW in FY2025 versus 56.8B KRW in FY2021, a compound +3.4%/yr. Reported net income was 5.3B KRW in FY2025, compounding −11.9%/yr from FY2021.
041920 screens 35% overvalued. Compare with InBody Co →
Peer Group
Health Care · 2227 stocks
How this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Healthcare Equipment & Supplies” was too small, so the broader sector is used.)
Valuation Multiples vs Health Care median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Healthcare Equipment & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| InBody Co 041830 | 50,900 KRW | 49,984 KRW | -2% |
| i-SENS, Inc 099190 | 15,270 KRW | 8,168 KRW | -47% |
| Value Added Technology Co 043150 | 16,800 KRW | 60,242 KRW | +259% |
| Meta Biomed Co 059210 | 3,830 KRW | 9,875 KRW | +158% |
| Sewoon Medical Co 100700 | 2,245 KRW | 6,054 KRW | +170% |
| MEDIC MEDIC | 0.2100 PHP | 0.1400 PHP | -33% |
| MEKICS CO., Ltd 058110 | 1,780 KRW | 1,584 KRW | -11% |
| CU Medical Systems, Inc 115480 | 1,753 KRW | 1,134 KRW | -35% |
| PeopleBio, Inc 304840 | 857.00 KRW | 905.70 KRW | +6% |
| Novartis AG NVSN | 2,742 MXN | 2,379 MXN | -13% |
Compare Mediana Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Mediana Co (041920) overvalued or undervalued?
What is the fair value of 041920?
What is the quality score of 041920?
What is the revenue of Mediana Co (041920)?
What is the net profit margin of 041920?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Mediana Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.